Robert Wasinger, senior vice president on McGuireWoods Consulting’s federal public affairs team, was quoted in a Sept. 17 cover story by CQ Magazine.
Was Policy Fellow for House Oversight and Government Reform Committee
Greg Walden, partner at McGuireWoods and senior advisor with McGuireWoods Consulting, recently discussed legal concerns, ethical considerations and policy around autonomous vehicles with the Corporate Counsel Business Journal.
In a Sept. 10 opinion piece for The Hill, McGuireWoods Consulting executive vice president and director, Frank Donatelli, compares the upcoming midterm elections and modern politics to a heavyweight fight.
Former Educator Touts Strong Legislative Affairs Background
Uncertainty surrounding trade is currently impacting energy development, particularly the procurement process for energy infrastructure projects. U.S.-imposed tariffs and quotas on steel and aluminum resulting from the Section 232 investigation have emerged as a real threat to the energy sector.
The federal legislative and regulatory work agenda for the rest of 2018 will include three top energy policy issues: (1) Renewable Fuel Standard (RFS) reform, (2) deregulation and (3) Russia sanctions.
This Week: The House and Senate return for final action before midterm elections. The House has only 11 legislative days left. Appropriations and opioid legislation are among the must-do items.
Your weekly North Carolina political news report.
Following the House vote last Friday, the Senate returned to Raleigh on Monday to vote on House Bill 3 and House Bill 4, which rewrite two of the six constitutional amendments appearing on the ballot this November. The legislature returned for the special session after a three-judge panel deemed the initial descriptions misleading and not fit to appear on the ballot. Both bills passed through the Senate with votes mostly among party lines.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.